Hallberg's Picture of Health

Ask Dr. Jon Hallberg (for the last time)
Dr. Jon Hallberg is leaving the radio airwaves, but on Thursday he spent one final hour with MPR News host Tom Crann and answered your medical questions.
Rethinking the 'aspirin a day' mantra for heart attack prevention
One baby aspirin a day keeps a heart attack away. At least that's the understanding a lot of adults have had for some time. But the U.S. Preventive Services Task Force is revisiting its guidance on using aspirin for heart health. It released a new draft for public comment this month.
Minnesota Board of Medical Practice amends medical license questions on mental health
Host Tom Crann spoke with Dr. Zeke McKinney, an occupational medicine doctor with Health Partners and president-elect of the Twin Cities Medical Society, about the Minnesota Board of Medical Practice’s move to amend the language on its application for medical licenses.
COVID-19 vaccine booster shots are on the way. What does that mean for you?
President Joe Biden’s administration is set to recommend COVID-19 vaccine booster shots for most Americans. Dr. Jon Hallberg joined host Tom Crann to answer common questions about the booster shots.
Mayo Platform’s Halamka on new WHO ethics guidelines for AI in medicine
The guidelines say humans — not machines — should remain the decision-makers, the technology must do no harm and doctors must be transparent to help patients understand how it's being used.
There's an emerging concern from health experts about the over-prescription of medicine with older adults. In response, a new movement is emerging — the exploration of “deprescribing” medications for their older patients. 
To test or not to test? What to do if you're vaccinated and exposed to COVID-19
Dr. Jon Hallberg walks us through the latest Centers for Disease Control and Prevention guidance on COVID-19 testing for those who have been vaccinated against the virus.
Hallberg: Benefits outweigh the risks of Johnson and Johnson vaccine
Officials at the U.S. Centers for Disease Control and Prevention have allowed providers to resume administering the one-dose vaccine, after reviewing the rare risk of blood clots associated with it.